Extracorporeal Membrane Oxygenation Machine Market Report Scope & Overview:

The Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 495.00 Million in 2025E and is projected to reach USD 725.99 Million by 2033, growing at a CAGR of 4.91% during 2026–2033.

The Extracorporeal Membrane Oxygenation (ECMO) Machine market is experiencing significant growth globally, driven by increasing prevalence of cardiac and respiratory diseases, rising adoption of advanced life-support technologies, and expanding critical care infrastructure. Key segments include pumps, oxygenators, and cannulae, while applications span cardiac support, respiratory support, and ECPR. The market growth is fueled by technological innovations, growing awareness among healthcare providers, and the increasing demand for portable and efficient ECMO solutions in hospitals and emergency care units.

On April 24, 2025, Eurosets unveiled Xtreme Rescue, the lightest portable ECMO device, and Landing Breathe, an advanced respiratory monitoring system, at EuroELSO 2025. These innovations, combined with Jetson’s ultra-light eVTOL, are designed to enable rapid life-saving interventions in remote and hard-to-reach areas, enhancing the versatility and reach of ECMO solutions.

Extracorporeal Membrane Oxygenation Machine Market Size and Forecast:

• Market Size in 2025: USD 495 Million

• Market Size by 2033: USD 725.99 Million

• CAGR: 4.91% (2026–2033)

• Base Year: 2025E

• Forecast Period: 2026–2033

• Historical Data: 2022–2024

To Get more information On Extracorporeal Membrane Oxygenation Machine Marke - Request Free Sample Report

The U.S. Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 144.85 Million in 2025E and is projected to reach USD 190.89 Million by 2033, growing at a CAGR of 4.91% during 2026–2033. driven by rising prevalence of cardiac and respiratory disorders, increasing demand for advanced life-support systems in hospitals, and growing adoption of portable and technologically advanced ECMO devices. Supportive government initiatives, expanding critical care infrastructure, and heightened awareness among healthcare professionals about ECMO’s life-saving potential are further fueling market growth, alongside ongoing innovations in device efficiency and patient management solutions.

Extracorporeal Membrane Oxygenation Machine Market Highlights:

• Robust market growth with rising prevalence of cardiac and respiratory diseases driving global demand for ECMO machines in critical care

• Technological innovation in portable, sensor-integrated, and user-friendly ECMO devices enhancing patient monitoring, long-term management, and clinical efficiency

• Strong market players with LivaNova’s RS Rating rising from 67 to 73 on October 6, 2025, reflecting improved technical performance and market leadership

• High costs and complex operation limiting adoption due to need for specialized personnel and regulatory hurdles

• Emerging opportunities from continuous R&D, government support, and advanced ECMO solutions creating growth potential in critical care worldwide

• Product launches driving adoption with Terumo’s Capiox SP-300 launched on March 25, 2025, offering enhanced sensors and monitoring and sustaining 70% market share in Japan

Extracorporeal Membrane Oxygenation Machine Market Drivers:

• Booming Demand for Advanced ECMO Machines Drives Global Critical Care Innovations

The global Extracorporeal Membrane Oxygenation (ECMO) Machine market is experiencing robust growth, driven by rising prevalence of cardiac and respiratory diseases and increasing demand for advanced life-support systems. Technological innovations, including portable, sensor-integrated, and user-friendly devices, are enhancing patient monitoring, long-term management, and clinical efficiency. Expanding awareness among healthcare professionals, supportive government initiatives, and continuous R&D investments in versatile ECMO solutions are further accelerating adoption. Hospitals and critical care centers are increasingly integrating ECMO machines to improve survival rates in severe cardiac and pulmonary cases. This dynamic environment presents significant opportunities for market expansion and innovation worldwide.

On October 6, 2025, LivaNova’s Relative Strength (RS) Rating increased from 67 to 73, signaling stronger technical performance and enhanced market leadership.

Extracorporeal Membrane Oxygenation Machine Market Restraints:

• High costs, complex operation, and regulatory hurdles are limiting the growth of the ECMO Machine market.

The growth of the ECMO Machine market faces several challenges that may limit widespread adoption. High costs of ECMO systems and associated consumables restrict accessibility, particularly in developing regions. Complex operation and the requirement for specialized, trained medical personnel can hinder deployment in smaller hospitals or emergency settings. Additionally, potential complications such as bleeding, infection, and thrombosis during ECMO therapy pose safety concerns, impacting clinician confidence. Regulatory hurdles, stringent approval processes, and variations in reimbursement policies across regions further slow market expansion. Limited awareness among healthcare providers in some regions and the need for continuous maintenance and monitoring also constrain market growth, despite the increasing demand for life-support technologies in critical care.

Extracorporeal Membrane Oxygenation Machine Market Opportunities:

• Driving Life-Saving Innovation: Growth Opportunities in the ECMO Machine Market

Rising prevalence of cardiac and respiratory diseases, coupled with increasing demand for advanced life-support systems, has led to greater adoption of ECMO machines. Technological innovations in portable, sensor-integrated devices result in improved patient monitoring and long-term management. Growing awareness among healthcare professionals and supportive government initiatives drive market growth, while continuous R&D and advancements in efficient, versatile ECMO solutions create sustained opportunities for expansion in critical care settings worldwide.

On March 25, 2025, Terumo launched the Capiox Centrifugal Pump Controller SP-300, an advanced ECMO device with enhanced sensors and monitoring for long-term patient management, marking 30 years of ECMO innovation and maintaining a leading 70% market share in Japan.

Extracorporeal Membrane Oxygenation Machine Market Segment Highlights:

• By Component: Dominant – Pumps (34.63% in 2025 → 32.38% in 2033); Fastest-Growing – Accessories (CAGR 10.05%)

• By Modality: Dominant – Veno-Arterial (39.38% in 2025 → 35.17% in 2033); Fastest-Growing – Veno-Venous (CAGR 6.22%)

• By Patient Type: Dominant – Adult (59.13% in 2025 → 53.88% in 2033); Fastest-Growing – Pediatric (CAGR 8.20%)

• By Application: Dominant – Cardiac (49.38% in 2025 → 45.63% in 2033); Fastest-Growing – ECPR (CAGR 7.85%)

Extracorporeal Membrane Oxygenation Machine Market Segment Analysis:

By Component, Pumps Dominating ECMO Machine Market While Accessories Lead as Fastest-Growing Segment

Pumps lead the ECMO Machine market, underscoring their essential role in life-support systems. Accessories are the fastest-growing segment, driven by increasing adoption of supplementary consumables and enhanced support devices in hospitals and critical care settings, reflecting the growing demand for comprehensive ECMO solutions.

By Modality, Veno-Arterial Dominating ECMO Machine Market While Veno-Venous Leads as Fastest-Growing Segment

Veno-Arterial dominates the ECMO Machine market, reflecting its widespread use in critical care. Veno-Venous is the fastest-growing modality, driven by increasing adoption in respiratory support and advanced life-saving procedures.

By Patient Type, Adult Dominating ECMO Machine Market While Pediatric Leads as Fastest-Growing Segment

Adult patients represent the dominant segment in ECMO usage due to higher prevalence of cardiac and respiratory conditions. Pediatric patients are the fastest-growing segment, fueled by rising awareness and improved adoption of ECMO in neonatal and pediatric intensive care units.

By Application, Cardiac Dominating ECMO Machine Market While ECPR Leads as Fastest-Growing Segment

Cardiac applications dominate the ECMO Machine market, reflecting its primary use in heart-related critical care. ECPR (Extracorporeal Cardiopulmonary Resuscitation) is the fastest-growing application, driven by increasing adoption in emergency and acute care settings for life-saving interventions.

Extracorporeal Membrane Oxygenation Machine Market Regional Highlights:

• By Region – Dominating: North America (44.17% in 2025 → 42.58% in 2033, CAGR 4.43%)

• Fastest-Growing Region: Asia-Pacific (26.76% in 2025 → 28.63% in 2033, CAGR 5.79%)

• Europe: 19.35% → 19.72% (CAGR 5.16%)

• South America: 5.17% → 5.27% (CAGR 5.15%)

• Middle East & Africa: 4.55% → 3.80% (CAGR 2.53%)

Extracorporeal Membrane Oxygenation Machine Market Regional Analysis:

North America Extracorporeal Membrane Oxygenation Machine Market Insights:

North America leads the Extracorporeal Membrane Oxygenation (ECMO) Machine market, holding the highest market share due to advanced healthcare infrastructure, early adoption of ECMO technologies, and growing prevalence of cardiac and respiratory diseases. Strong hospital networks and high investment in critical care contribute to sustained market dominance and steady growth.

Get Customized Report as per Your Business Requirement - Enquiry Now

U.S. Extracorporeal Membrane Oxygenation Machine Market Insights:

The United States is the dominant country in the Extracorporeal Membrane Oxygenation (ECMO) Machine market, driven by advanced healthcare infrastructure, high adoption of ECMO technologies, strong critical care facilities, and increasing prevalence of cardiac and respiratory conditions. It accounts for the largest share of North America’s market.

Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market Insights:

Asia-Pacific is the fastest-growing region in the Extracorporeal Membrane Oxygenation (ECMO) Machine market, driven by increasing healthcare investments, rising prevalence of cardiac and respiratory diseases, and expanding critical care infrastructure. Countries like China, India, and Japan are adopting advanced ECMO technologies, while growing awareness, government initiatives, and rising hospital capacities are accelerating market growth across the region.

• China Extracorporeal Membrane Oxygenation Machine Market Insights:

China leads the Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Machine market, driven by rapid healthcare infrastructure development, increasing prevalence of cardiac and respiratory diseases, rising hospital capacities, and growing adoption of advanced ECMO technologies across major medical centers.

Europe Extracorporeal Membrane Oxygenation Machine Market Insights:

The Europe Extracorporeal Membrane Oxygenation (ECMO) Machine market is witnessing steady growth, supported by advanced healthcare infrastructure, increasing government initiatives, and rising prevalence of cardiac and respiratory conditions. Countries like Germany and the U.K. are adopting innovative ECMO technologies, enhancing patient outcomes and driving consistent market expansion across the region.

• Germany Extracorporeal Membrane Oxygenation Machine Market Insights:

Germany is the dominant country in the Europe Extracorporeal Membrane Oxygenation (ECMO) Machine market, driven by advanced healthcare infrastructure, high adoption of ECMO technologies, well-established critical care facilities, and strong government support for medical innovations, making it the largest contributor to the region’s market growth.

Latin America Extracorporeal Membrane Oxygenation Machine Market Insights:

The Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine market is steadily expanding, supported by rising prevalence of cardiac and respiratory diseases, increasing healthcare investments, and growing awareness of advanced life support technologies. Countries like Brazil are leading the adoption of ECMO systems, with hospitals and specialized medical centers enhancing critical care capabilities and improving patient outcomes across the region.

• Brazil Extracorporeal Membrane Oxygenation Machine Market Insights:

Brazil is the dominant country contributing to the Latin America Extracorporeal Membrane Oxygenation (ECMO) Machine market, driven by expanding healthcare infrastructure, increasing prevalence of cardiac and respiratory diseases, rising adoption of advanced ECMO technologies, and growing investment in critical care facilities across hospitals and specialized medical centers.

Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market Insights:

The Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine market is experiencing moderate growth, driven by gradual healthcare infrastructure development, rising awareness of advanced life support technologies, and increasing prevalence of cardiac and respiratory diseases. Countries like Saudi Arabia are leading adoption, supported by government initiatives and expanding critical care facilities.

• Saudi Arabia Extracorporeal Membrane Oxygenation Machine Market Insights:

Saudi Arabia is the dominant country in the Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Machine market, driven by growing healthcare infrastructure, increasing prevalence of cardiac and respiratory diseases, rising adoption of advanced ECMO technologies, and government support for critical care and advanced medical treatments.

Extracorporeal Membrane Oxygenation Machine Market Competitive Landscape:

Getinge AB – Established in 1904, Getinge AB is a global medtech company specializing in advanced healthcare solutions, including extracorporeal membrane oxygenation (ECMO), surgical equipment, and infection control systems. The company focuses on improving patient outcomes through innovative technologies, offering a broad product portfolio, global presence, and strategic emphasis on high-growth critical care segments.

• In January 2025, Getinge announced it will phase out its struggling surgical perfusion business, reallocating resources to higher-growth areas such as extracorporeal membrane oxygenation (ECMO) and transplant care, while analysts expect LivaNova to benefit from the $41 million in sales Getinge is exiting.

LivaNova PLC – Established in 1996, LivaNova PLC is a global medical technology company specializing in cardiopulmonary and neuromodulation solutions. Headquartered in London, the company operates in over 100 countries, delivering innovative medical devices and therapies that improve patient outcomes, with a focus on advanced ECMO systems, heart-lung machines, and neuromodulation technologies.

• In January 2024, LivaNova announced the wind-down of its ACS business, retaining profitable standalone cannulae while discontinuing LifeSPARC™ and Hemolung™ systems, aiming to streamline operations and strengthen growth in cardiopulmonary and neuromodulation segments.

Extracorporeal Membrane Oxygenation Machine Market Key Players:

• Getinge AB

• Medtronic plc

• LivaNova PLC

• Terumo Corporation

• Fresenius Medical Care / Xenios AG

• Eurosets S.R.L.

• Nipro Corporation

• MicroPort Scientific Corporation

• Maquet Holding

• Medos Medizintechnik

• ABIOMED

• Spectrum Medical

• CytoSorbents Corporation

• Xenios AG ECMO Systems

• Abbott Laboratories

• ALung Technologies Inc.

• Braile Biomedical

• Origen Biomedical, Inc.

• Medica S.p.A.

• Sorin Group